Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

Blood (2016) 127 (8): 1017–1023.

https://doi.org/10.1182/blood-2015-10-676098

Published: 2016

Includes: Supplemental data

Journal Articles

T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy

Elaine M. Sloand, J. Joseph Melenhorst, Zachary C. G. Tucker, Loretta Pfannes, Jason M. Brenchley, Agnes Yong, Valeria Visconte, Colin Wu, Emma Gostick, Phillip Scheinberg, Matthew J. Olnes, Daniel C. Douek, David A. Price, A. John Barrett, Neal S. Young

Blood (2011) 117 (9): 2691–2699.

https://doi.org/10.1182/blood-2010-04-277921

Published: 2011

Includes: Supplemental data

Journal Articles

In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to BMI-1 Protein Correlate with Higher Expression of BMI-1 in Leukemia Progenitors, and May Contribute to Improved Outcome After Allogeneic Stem Cell Transplantation.

S. M. Agnes Yong, MD, PhD, Nicole Stephens, BS, Bipin N. Savani, MD, Yixin Li, PhD, Rhoda Eniafe, BS, Keyvan Keyvanfar, BS, Roger J Kurlander, MD, Katayoun Rezvani, MD, PhD, A. John Barrett, MD

Blood (2009) 114 (22): 192.

https://doi.org/10.1182/blood.V114.22.192.192

Published: 2009

Journal Articles

WT1-Specific CD8+ T Lymphocytes May Participate in the Elimination of Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.

Katayoun Rezvani, MD, PhD, Agnes Yong, MD, PhD, Stephan Mielke, MD, Bipin N. Savani, MD, David A. Price, MD, PhD, Emma Gostick, Daniel C. Douek, MD, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 3679.

https://doi.org/10.1182/blood.V108.11.3679.3679

Published: 2006

Journal Articles

Selective Depletion of CD25+ Host-Reactive Donor Lymphocytes from Allografts Preserves a CD25− CD4+foxp3+ Fraction of T Cells and Thereby Provides a Source for Efficient Reconstitution of Regulatory T Cells and Additional GVHD Control.

Stephan Mielke, MD, Katayoun Rezvani, MD, PhD, Scott R. Solomon, MD, Bipin N. Savani, MD, Raquel Nunes, MD, Agnes Yong, MD, PhD, John Schindler, PhD, Elizabeth J. Read, MD, Ellen S. Vitetta, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 308.

https://doi.org/10.1182/blood.V108.11.308.308

Published: 2006

Journal Articles

Total Lymphocyte and Natural Killer (NK) Cell Count Day 30 Post-Transplant Strongly Predict Transplant Outcome after T Cell Depleted Allogeneic Stem Cell Transplantation.

Bipin N. Savani, MD, Stephan Mielke, MD, Katayoun Rezvani, MD, PhD, Agnes Yong, MD, PhD, Nancy Hensel, Elizabeth J. Read, MD, Richard Childs, A. John Barrett, MD

Blood (2006) 108 (11): 2993.

https://doi.org/10.1182/blood.V108.11.2993.2993

Published: 2006

Journal Articles

Cytotoxic CD8 T Cell Immune Responses to Wilms Tumor Protein (WT-1) Characterizes Immunosuppression-Responsive Myelodysplasia (MDS).

Elaine M. Sloand, MD, Katayoun Rezvani, MD, PhD, Agnes Yong, MD, PhD, Daniel Douek, PhD, Roger Kurlander, MD, David Price, PhD, John Barrett, MD, Neal S. Young, MD

Blood (2006) 108 (11): 849.

https://doi.org/10.1182/blood.V108.11.849.849

Published: 2006

Journal Articles

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Francesco Dazzi, Richard M. Szydlo, Nicholas C. P. Cross, Charles Craddock, Jaspal Kaeda, Ed Kanfer, Kate Cwynarski, Eduardo Olavarria, Agnes Yong, Jane F. Apperley, John M. Goldman

Blood (2000) 96 (8): 2712–2716.

https://doi.org/10.1182/blood.V96.8.2712

Published: 2000

NARROW

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy

In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to BMI-1 Protein Correlate with Higher Expression of BMI-1 in Leukemia Progenitors, and May Contribute to Improved Outcome After Allogeneic Stem Cell Transplantation.

WT1-Specific CD8+ T Lymphocytes May Participate in the Elimination of Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.

Selective Depletion of CD25+ Host-Reactive Donor Lymphocytes from Allografts Preserves a CD25− CD4+foxp3+ Fraction of T Cells and Thereby Provides a Source for Efficient Reconstitution of Regulatory T Cells and Additional GVHD Control.

Total Lymphocyte and Natural Killer (NK) Cell Count Day 30 Post-Transplant Strongly Predict Transplant Outcome after T Cell Depleted Allogeneic Stem Cell Transplantation.

Cytotoxic CD8 T Cell Immune Responses to Wilms Tumor Protein (WT-1) Characterizes Immunosuppression-Responsive Myelodysplasia (MDS).

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only